From Bench to Clinic—The Potential of New Sequencing Tools

Sponsored content brought to you by As genome sequencing technology advances, researchers are increasingly exploring emerging tools for a host of potential clinical applications. Andrew...
Protein (ubiquitin) molecule (cartoon model). Stylized image.

In-Cell Protein Footprinting: A New Tool for Proteome-Wide Structural Biology

VIEW NOW Broadcast Date: June 26, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Protein structure must be studied in its native cellular environment, otherwise,...
isoplexis eBook cover

Single-Cell Functional Proteomics Accelerates Immunotherapy Development Opportunities from Pre-Clinical to Clinical Stages

IsoPlexis’ next generation systems provide actionable potency, safety, and patient difference metrics by detecting highly potent single cell functional subsets for the first time.

Rethinking Rx-Dx Codevelopment

Codevelopment is an intermittent and uncertain process. Adopting an agnostic approach to the challenges associated with platform and method selection provide added degrees of freedom for strategic development and selection of the most appropriate clinical trial assay.

Cancer Gene Variant Detection Using a Pre-Optimized Sample to Report Workflow

REGISTER NOW Broadcast Date: September 12, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET BRCA1/BRCA2 genes represent the best examples for our current understanding of...
Researchers Operating Chemistry Analyzer Machine

Better Understanding of Post-Translation Modifications Driving Innovation

Takeda has taken great strides in incorporating a patient-centric approach to drug development through the use of minimally invasive and less frequent testing procedures while maintaining the power and rigor of the clinical trial.

Emerging Technologies in Next-Gen Sequencing

RNA and sequencing technologies have the potential to unlock the mystery of our every dynamic transcriptome.
video

The Promise and Challenge of Immuno-Oncology

This webinar explores the complexity of diagnostic testing in immuno-oncology and therapeutic innovations that have emerged in the field.

LeukoVantage: A Quest/QIAGEN Partnership Providing Clinical Insights Into Myeloid Malignancies

In this webinar, we will describe Quest’s LeukoVantage assay, an NGS test designed specifically for detecting clinically relevant variants in myeloid malignancies, and its partnership with N-of-One, a QIAGEN company, for expert interpretation.
video

Addressing Challenges of NGS Data Interpretation for Hematologic Malignancies

This groundbreaking webinar will discuss how NGS technologies have aided clinicians in the diagnosis and treatment of hematologic cancer.
Scroll Up